Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Today, on the 80-year anniversary of the Nobel Prize being awarded for the discovery and development of penicillin, Dr Alistair Farley, Scientific Lead at the Ineos Oxford Institute for antimicrobial research (IOI), urges that the collaboration behind this achievement is channelled again today to address one of the greatest global medical challenges of our time.

Packages of pills of different colours and shapes © sprng23, Getty Images

On 10 December 1945, Alexander Fleming, Howard Florey, and Ernst Chain were jointly awarded the Nobel Prize in Physiology or Medicine ‘for the discovery of penicillin and its curative effect in various infectious diseases.’ The discovery of penicillin and its subsequent industrial production during World War Two is rightly hailed as one of the biggest medical breakthroughs of the 20th century. Penicillin played a pivotal role for millions of allied soldiers and over the last 80 years has saved hundreds of millions of lives.

The development of penicillin established a new model for translational research. Fleming’s discovery of penicillin from the Penicilium mould was published as a curious observation. Building on these findings, Florey, Chain and Norman Heatley at the Dunn School of Pathology in Oxford isolated penicillin for the first time, with bedpans being used to grow and ferment the mould. Although quantities of pure penicillin were limited, they were sufficient to demonstrate its curative effects in mice and a human patient. The penicillin program was subsequently supported by a grant by the Rockefeller foundation, then by involvement of British and US pharmaceutical companies, backed by their governments. This led remarkably quickly to mass production of penicillin, in an early example of transatlantic collaboration for biomedical research.

 

Read the full story on the University of Oxford website.